France· FR:67170230
VUMERITY 231 mg, gélule gastro-résistante
A diroximel fumarate product containing fumarate de diroximel, registered in France by BIOGEN NETHERLANDS (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Diroximel fumarate is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AX09 (diroximel fumarate), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Diroximel fumarate · ATC L04AX09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of diroximel fumarate costs, country by country.
Normalised to the WHO defined daily dose (0.924 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Diroximel fumarate · price per daily dose (0.924 g)
USD · FX 28 Sept 2026
- CH Switzerland$48.25
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FUMARATE DE DIROXIMEL
- Manufacturer
- BIOGEN NETHERLANDS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- L04AX09
- ATC class
- Diroximel fumarate
- Defined daily dose
- 0.924 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302416841 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 gélule(s)EUR 770.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for diroximel fumarate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diroximel fumarate · interactions on record
277 records
- 29 severe
- 248 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diroximel fumarate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVUMERITY 231 MG CAPSULAS DURAS GASTRORRESISTENTESBiogen Netherlands B.V.
- IcelandVumerityBiogen Netherlands B.V.
- NetherlandsVumerity 231 mg maagsapresistente capsules, hardBiogen Netherlands B.V.
- PolandVumerityBiogen Netherlands B.V.
- SwitzerlandVumerity 231 mg, Magensaftresistente HartkapselnBiogen Switzerland AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b2f0625-175f-4c35-81a7-70d22c60b1c4 GET /v1/drugs/7b2f0625-175f-4c35-81a7-70d22c60b1c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67170230",
"date_amm": "2021-11-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1585",
"substance": "FUMARATE DE DIROXIMEL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule gastro-résistant(e)",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about diroximel fumarate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.